Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
9954 | 1040 | 38.6 | 83% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | MITOCHONDRIAL TOXICITY | Author keyword | 44 | 43% | 8% | 78 |
2 | DISTAL SENSORY POLYNEUROPATHY | Author keyword | 24 | 91% | 1% | 10 |
3 | ANTIRETROVIRAL TOXIC NEUROPATHY | Author keyword | 13 | 80% | 1% | 8 |
4 | NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS | Author keyword | 9 | 26% | 3% | 32 |
5 | HIV ASSOCIATED SENSORY NEUROPATHY | Author keyword | 9 | 83% | 0% | 5 |
6 | HYPERLACTATAEMIA | Author keyword | 8 | 48% | 1% | 12 |
7 | HYPERLACTATEMIA | Author keyword | 7 | 30% | 2% | 20 |
8 | NRTI | Author keyword | 7 | 25% | 2% | 24 |
9 | NEURO AIDS PROGRAM | Address | 6 | 71% | 0% | 5 |
10 | STAVUDINE | Author keyword | 6 | 14% | 4% | 39 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | DISTAL SENSORY POLYNEUROPATHY | 65 | 76% | 4% | 45 |
2 | HYPERLACTATEMIA | 22 | 36% | 5% | 49 |
3 | SYMPTOMATIC HYPERLACTATEMIA | 21 | 78% | 1% | 14 |
4 | ZIDOVUDINE INDUCED MYOPATHY | 21 | 90% | 1% | 9 |
5 | ZIDOVUDINE MYOPATHY | 19 | 68% | 2% | 17 |
6 | MITOCHONDRIAL TOXICITY | 19 | 21% | 8% | 80 |
7 | THERAPY RELATED LIPODYSTROPHY | 19 | 71% | 1% | 15 |
8 | ANTIRETROVIRAL NUCLEOSIDE ANALOGS | 18 | 89% | 1% | 8 |
9 | ERYTHROCEBUS PATAS MONKEYS | 18 | 89% | 1% | 8 |
10 | TOXIC NEUROPATHY | 13 | 51% | 2% | 18 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Neurological and Psychiatric Adverse Effects of Antiretroviral Drugs | 2014 | 8 | 153 | 35% |
Fetal consequences of maternal antiretroviral nucleoside reverse transcriptase inhibitor use in human and nonhuman primate pregnancy | 2015 | 1 | 28 | 43% |
HIV-Associated Sensory Neuropathy: Risk Factors and Genetics | 2012 | 19 | 82 | 60% |
Epidemiology of HIV-Related Neuropathy: A Systematic Literature Review | 2012 | 13 | 48 | 69% |
Mitochondrial toxicity of NRTI antiviral drugs: An integrated cellular perspective | 2003 | 243 | 137 | 34% |
Manifestations of HIV infection in the peripheral nervous system | 2013 | 9 | 120 | 48% |
Pharmacological Treatment of Painful HIV-Associated Sensory Neuropathy: A Systematic Review and Meta-Analysis of Randomised Controlled Trials | 2010 | 49 | 57 | 37% |
A brief overview of mechanisms of mitochondrial toxicity from NRTIs | 2007 | 63 | 77 | 49% |
Mechanisms of zidovudine-induced mitochondrial toxicity and myopathy | 2008 | 51 | 43 | 42% |
Adverse effects of reverse transcriptase inhibitors: mitochondrial toxicity as common pathway | 1998 | 531 | 86 | 35% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | NEURO AIDS PROGRAM | 6 | 71% | 0.5% | 5 |
2 | HAWAII AIDS CLIN PROGRAM | 2 | 22% | 0.9% | 9 |
3 | CHAIR IMMUNOLSECT GEN PATHOL | 2 | 67% | 0.2% | 2 |
4 | GENET ABIL 2 | 2 | 67% | 0.2% | 2 |
5 | PHYSIOL INVEST | 2 | 67% | 0.2% | 2 |
6 | MITOCHONDRIAL | 2 | 21% | 0.7% | 7 |
7 | MITOCHONDRIAL FUNCTIONALISM | 1 | 100% | 0.2% | 2 |
8 | PATHOPHYSIOL AIDS UNIT | 1 | 100% | 0.2% | 2 |
9 | POKDISUS WORKING GRP AIDS | 1 | 100% | 0.2% | 2 |
10 | WITWATERSRAND REPROD HLTH HIV WRHI | 1 | 100% | 0.2% | 2 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000155128 | ZIDOVUDINE//AZT//DIDANOSINE |
2 | 0.0000142739 | LIPODYSTROPHY//LIPOATROPHY//PROGRAM NUTR METAB |
3 | 0.0000118750 | HIV RELATED PULMONARY HYPERTENSION//HIV ASSOCIATED CARDIOMYOPATHY//CA2M |
4 | 0.0000111987 | VACUOLAR MYELOPATHY//AIDS DEMENTIA COMPLEX//CEREBRAL TOXOPLASMOSIS |
5 | 0.0000099127 | POLG//MNGIE//DEOXYRIBONUCLEOSIDE KINASE |
6 | 0.0000090434 | METROPOLITAN VASC SERV//RHEUMATIC MANIFESTATIONS//HIV ARTHRITIS |
7 | 0.0000070626 | FLUORESCENT FOCUS ASSAY//FUYOU BRANCH//GLOBAL NEUROL PROGRAM |
8 | 0.0000062012 | ACETYL L CARNITINE//ALCAR//ACETYL L CARNITINE ALC |
9 | 0.0000055645 | EMI U 9922//UNITE PHYSIOPATHOL INFECT LENTIVIRALES//DIPARTIMENTO IGIENE MED PREVENT SANITA PUBBL |
10 | 0.0000054855 | EFAVIRENZ//CYP2B6//NEVIRAPINE |